TR200000133T2 - Treatment of diabetes (diabetic) with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor. - Google Patents
Treatment of diabetes (diabetic) with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor.Info
- Publication number
- TR200000133T2 TR200000133T2 TR2000/00133T TR200000133T TR200000133T2 TR 200000133 T2 TR200000133 T2 TR 200000133T2 TR 2000/00133 T TR2000/00133 T TR 2000/00133T TR 200000133 T TR200000133 T TR 200000133T TR 200000133 T2 TR200000133 T2 TR 200000133T2
- Authority
- TR
- Turkey
- Prior art keywords
- diabetes
- thiazolidinedione
- diabetic
- treatment
- insulin secretagogue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Etkili, toksik olmayan ve eczacilik teknolojisi bakimindan kabul edilebilir tutarda bir ensülin yönünden duyarli duruma getiricinin, bir insülin salgilattiricisinin bir alfa glükodinaz inhibitör (yasaklayici, engelleyici) antihiperglisemik etkenin, bunlara gereksinmesi bulunan bir memeliye verilmesini içeren diabetes mellitus'un ve memelide diabetes mellitus ile iliskili durumlarin tedavi edilmeleri için yöntem ile bu gibi yöntemin kullanilmasina yarar bilesim.Diabetes mellitus with diabetes mellitus, which includes the delivery of an effective, non-toxic and pharmaceutically acceptable insulin sensitizer, an insulin secretagogue, an alpha glucodinase inhibitor (prohibitive, inhibitory) antihyperglycemic agent to a mammal that needs them. I know that it is useful to use this method with the method to treat the conditions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9715298A GB9715298D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200000133T2 true TR200000133T2 (en) | 2000-09-21 |
Family
ID=10816170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/00133T TR200000133T2 (en) | 1997-07-18 | 1998-07-16 | Treatment of diabetes (diabetic) with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor. |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP1001784A1 (en) |
| JP (1) | JP2001510160A (en) |
| KR (1) | KR20010021952A (en) |
| CN (1) | CN1263467A (en) |
| AP (1) | AP2000001735A0 (en) |
| AR (2) | AR016350A1 (en) |
| AU (1) | AU8449098A (en) |
| BG (1) | BG104062A (en) |
| BR (1) | BR9810292A (en) |
| CA (1) | CA2297133A1 (en) |
| CO (1) | CO4940489A1 (en) |
| DZ (1) | DZ2563A1 (en) |
| EA (1) | EA200000140A1 (en) |
| GB (1) | GB9715298D0 (en) |
| HU (1) | HUP0003626A3 (en) |
| ID (1) | ID23804A (en) |
| IL (1) | IL133907A0 (en) |
| MA (1) | MA24608A1 (en) |
| NO (1) | NO20000230D0 (en) |
| OA (1) | OA11312A (en) |
| PE (1) | PE99499A1 (en) |
| PL (1) | PL338140A1 (en) |
| SK (1) | SK612000A3 (en) |
| TR (1) | TR200000133T2 (en) |
| UY (1) | UY25101A1 (en) |
| WO (1) | WO1999003478A1 (en) |
| ZA (1) | ZA986364B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| ATE372782T1 (en) | 1999-06-21 | 2007-09-15 | Lilly Co Eli | SYNERGITIC USE OF THIAZOLIDINEDIONES AND GLUCAGONE-LIKE PEPTIDE-1 AND THEIR AGONISTS FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES |
| JP2003520226A (en) * | 2000-01-21 | 2003-07-02 | ノバルティス アクチエンゲゼルシャフト | Combination comprising a dipeptidyl peptidase-IV inhibitor and an antidiabetic agent |
| WO2001062295A1 (en) * | 2000-02-24 | 2001-08-30 | Takeda Chemical Industries, Ltd. | Drugs containing combined active ingredients |
| JP4917712B2 (en) * | 2000-02-24 | 2012-04-18 | 武田薬品工業株式会社 | Concomitant medication |
| EP1738751B1 (en) | 2001-01-12 | 2011-05-11 | Sun Pharma Advanced Research Company Ltd | Spaced drug delivery system |
| FR2832930A1 (en) * | 2001-12-03 | 2003-06-06 | Lipha | PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES |
| CA2540225C (en) | 2003-10-31 | 2012-03-06 | Takeda Pharmaceutical Company Limited | Solid preparation of pioglitazone, glimepiride and a polyoxyethylene sorbitan fatty acid ester |
| CN101103993B (en) * | 2006-07-14 | 2011-03-30 | 北京华安佛医药研究中心有限公司 | Hypoglycemic medicine composition |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2101866T3 (en) * | 1991-08-26 | 1997-07-16 | Upjohn Co | LIQUID FOOD PRODUCT CONTAINING 3-GUANIDINOPROPIONIC ACID. |
| US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1997
- 1997-07-18 GB GB9715298A patent/GB9715298D0/en active Pending
-
1998
- 1998-07-15 DZ DZ980173A patent/DZ2563A1/en active
- 1998-07-16 EA EA200000140A patent/EA200000140A1/en unknown
- 1998-07-16 AR ARP980103482A patent/AR016350A1/en unknown
- 1998-07-16 EP EP98935129A patent/EP1001784A1/en not_active Withdrawn
- 1998-07-16 BR BR9810292-3A patent/BR9810292A/en not_active IP Right Cessation
- 1998-07-16 SK SK61-2000A patent/SK612000A3/en unknown
- 1998-07-16 CN CN98807147A patent/CN1263467A/en active Pending
- 1998-07-16 TR TR2000/00133T patent/TR200000133T2/en unknown
- 1998-07-16 JP JP2000502777A patent/JP2001510160A/en active Pending
- 1998-07-16 CA CA002297133A patent/CA2297133A1/en not_active Abandoned
- 1998-07-16 AU AU84490/98A patent/AU8449098A/en not_active Abandoned
- 1998-07-16 MA MA25172A patent/MA24608A1/en unknown
- 1998-07-16 KR KR1020007000517A patent/KR20010021952A/en not_active Application Discontinuation
- 1998-07-16 HU HU0003626A patent/HUP0003626A3/en unknown
- 1998-07-16 PL PL98338140A patent/PL338140A1/en unknown
- 1998-07-16 PE PE1998000630A patent/PE99499A1/en not_active Application Discontinuation
- 1998-07-16 WO PCT/GB1998/002112 patent/WO1999003478A1/en not_active Application Discontinuation
- 1998-07-16 IL IL13390798A patent/IL133907A0/en unknown
- 1998-07-16 ID IDW20000077A patent/ID23804A/en unknown
- 1998-07-17 UY UY25101A patent/UY25101A1/en not_active Application Discontinuation
- 1998-07-17 ZA ZA9806364A patent/ZA986364B/en unknown
- 1998-07-17 CO CO98040749A patent/CO4940489A1/en unknown
-
1999
- 1999-06-28 AR ARP990103110A patent/AR019724A2/en unknown
-
2000
- 2000-01-06 BG BG104062A patent/BG104062A/en unknown
- 2000-01-14 AP APAP/P/2000/001735A patent/AP2000001735A0/en unknown
- 2000-01-17 NO NO20000230A patent/NO20000230D0/en not_active Application Discontinuation
- 2000-01-18 OA OA1200000013A patent/OA11312A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200000140A1 (en) | 2000-06-26 |
| CN1263467A (en) | 2000-08-16 |
| SK612000A3 (en) | 2000-07-11 |
| IL133907A0 (en) | 2001-04-30 |
| JP2001510160A (en) | 2001-07-31 |
| AP2000001735A0 (en) | 2000-01-16 |
| DZ2563A1 (en) | 2003-02-15 |
| UY25101A1 (en) | 2000-12-29 |
| KR20010021952A (en) | 2001-03-15 |
| ZA986364B (en) | 2000-01-17 |
| CO4940489A1 (en) | 2000-07-24 |
| WO1999003478A1 (en) | 1999-01-28 |
| CA2297133A1 (en) | 1999-01-28 |
| NO20000230L (en) | 2000-01-17 |
| EP1001784A1 (en) | 2000-05-24 |
| NO20000230D0 (en) | 2000-01-17 |
| HUP0003626A2 (en) | 2001-05-28 |
| AR019724A2 (en) | 2002-03-13 |
| PL338140A1 (en) | 2000-09-25 |
| PE99499A1 (en) | 1999-12-18 |
| AU8449098A (en) | 1999-02-10 |
| BG104062A (en) | 2000-11-30 |
| MA24608A1 (en) | 1999-04-01 |
| BR9810292A (en) | 2000-09-19 |
| ID23804A (en) | 2000-05-11 |
| HUP0003626A3 (en) | 2001-12-28 |
| AR016350A1 (en) | 2001-07-04 |
| GB9715298D0 (en) | 1997-09-24 |
| OA11312A (en) | 2003-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20090846L (en) | Combination and pharmaceutical composition for the treatment of diabetes and its use | |
| TR200100773T2 (en) | Diabetes treatment method using an aP2 inhibitor and combination | |
| EA200300036A1 (en) | COMBINATION OF DIPEPTIDYLPEPIDIDASE INHIBITORS IV AND OTHER ANTI-DIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS | |
| EA200100541A1 (en) | PHARMACEUTICAL COMPOSITION WITH MODIFIED SURVIVAL OF THE SENSITIZER TO INSULIN AND OTHER ANTI-DIABETIC AGENTS | |
| NO970519L (en) | Treatment of type II diabetes mellitus with amylin agonists | |
| BR0308904A (en) | Method of treatment of gastroparesis and use of a glp-1 compound | |
| TR200000133T2 (en) | Treatment of diabetes (diabetic) with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor. | |
| TR200000134T2 (en) | Treatment of diabetes (diabetes) with thiazolidinedione, insulin secretagogue and biguanide. | |
| EA200000042A1 (en) | METHOD OF TREATING DIABETES BY ROSIGLITAZON AND INSULIN | |
| GB2380939B (en) | Treatment or prevention of auto-immune diseases | |
| NO996270L (en) | Treatment of diabetes with thiazolidinedione and <alfa> glucosidase inhibitor | |
| TR200000135T2 (en) | Diabetes treatment with thiazolidinedione and sulfonylurea. | |
| TR199903096T2 (en) | Treatment of diabetes with thiazolidinedione and sulfonylureas. | |
| ES2181923T3 (en) | 4-HYDROXICUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF DIABET IS MELLITUS NOT INSULIN DEPENDENT. | |
| ES2166406T3 (en) | USE OF 1,5-BENZODIAZEPIN DERIVATIVES FOR THE CONTROL OF GASTRIC EMPTYING IN PATIENTS WITH MELLITUS DIABETES NOT DEPENDENT ON INSULIN. | |
| ES2135353A1 (en) | USE OF 17 beta -ESTRADIOL, ANALOGS AND DERIVATIVES THEREOF FOR THE TREATMENT OF DIABETES MELLITUS AND ITS MANIFESTATIONS | |
| IT1295954B1 (en) | USE OF A CHEMICAL AGENT TO DECREASE THE VARIATIONS IN LIFE AND THE CONSTIPATION EFFECT RELATED TO THE RECRUITMENT OF OTHER AGENTS | |
| EA199800177A1 (en) | A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus | |
| AU2002319381A1 (en) | Use of antidiabetics for making a medicine with cicatrizing effect | |
| HUP0002669A2 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| EA200000419A1 (en) | APPLICATION OF THIAZOLIDINDION FOR THE TREATMENT OF HYPERGLYCEMIA | |
| ECSP993146A (en) | TREATMENT METHOD FOR DIABETES USING AN AP2 INHIBITOR AND ITS COMBINATION |